Tectonic Therapeutic, Inc.
TECX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001681087
In the last 90 days, Tectonic Therapeutic, Inc. insiders filed 0 open-market purchases and 2 sales; 122 institutions reported holding it in 13F filings for Q2 2026, worth $479.9M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Tectonic Therapeutic, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- −7 vs. Q3 2021
- Shares held
- 35.0M
- +5.23M (+17.6%) vs. Q3 2021
- Total value
- $134.9M
- −$31.6M (−19.0%) vs. Q3 2021
- New holders
- 17
- 24 more added
- Sold out
- 24
- 43 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TECX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $479.9M |
| Q1 2026 | 111 | $426.8M |
| Q4 2025 | 105 | $288.1M |
| Q3 2025 | 99 | $189.9M |
| Q2 2025 | 82 | $240.7M |
| Q1 2025 | 78 | $198.8M |
| Q4 2024 | 70 | $354.9M |
| Q3 2024 | 53 | $217.4M |
| Q2 2024 | 40 | $88.1M |
| Q1 2024 | 47 | $35.2M |
| Q4 2023 | 45 | $32.2M |
| Q3 2023 | 48 | $39.9M |
| Q2 2023 | 41 | $18.9M |
| Q1 2023 | 48 | $22.8M |
| Q4 2022 | 45 | $14.8M |
| Q3 2022 | 54 | $15.7M |
| Q2 2022 | 64 | $23.8M |
| Q1 2022 | 81 | $38.8M |
| Q4 2021 | 94 | $134.9M |
| Q3 2021 | 101 | $166.5M |
| Q2 2021 | 97 | $287.7M |
| Q1 2021 | 99 | $423.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Tectonic Therapeutic, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −29,911−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −22,244−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −20,823−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −19,762−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| 1623 Capital LLC | 0 | $0 | 0.00% | −18,479−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −14,655−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,406−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −3,172−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,111−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −1,951−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −995−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −805−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −216−100.0% | Sold out |
| Savior LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |